ReviewArchives of toxicology2026
Differential endocrine and reproductive responses across generations: highlighting the need for holistic assessment in regulatory toxicology.
Review in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In 2024, Bichlmaier published a retrospective statistical analysis of 112 Extended One-Generation Reproductive Toxicity Studies (EOGRTS), concluding that reproductive and endocrine effects rarely demonstrate cross-generational continuity. He contended that findings limited to a single generation should be interpreted independently and need not exhibit generational consistency to be toxicologically relevant. We question the underlying premise that there is no biological plausibility for continuity as this conflicts with prevailing scientific and regulatory approaches that emphasise biological coherence and mechanistic relationship. The current review presents a re-analysis of the data used by Bichlmaier and critically examines the analytical framework used, considers established toxicological principles and regulatory standards and draws on the critiques presented by Arts et al. (Arch Toxicol 99:3047-3305, 2025). Through a comprehensive weight-of-evidence critique, we demonstrate that the analytical assumptions underpinning Bichlmaier's study fail to account for core principles such as adversity, dose-response relationships, effect magnitude, and mechanistic coherence, thereby undermining the utility of the findings for regulatory toxicology.
Indexed as
Identifiers
41807784What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.